Exploiting natural peptide diversity: Novel research tools and drug leads

Current Opinion in Biotechnology

Volumn 15, Issue 6, 2004, Pages 599-606

  Adermann, Knut ^a   John, Harald ^a   Ständker, Ludger ^a   Forssmann, Wolf Georg ^a  

^a IPF PHARMACEUTICALS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL EFFECTS; CHEMOATTRACTANTS; PEPTIDES; PROTEASE INHIBITORS;

BIODIVERSITY; BIOMARKERS; BIOTECHNOLOGY; CELLS; DRUG PRODUCTS; ENZYME INHIBITION; ENZYME KINETICS; ENZYMES; MASS SPECTROMETRY;

AMINO ACIDS;

ALPHA A CONOTOXIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; BENZODIAZEPINE; CHEMERIN; CONOTOXIN; DEFENSIN; G PROTEIN COUPLED RECEPTOR; GHRELIN; HEMORPHIN 4; HEPCIDIN; LEAP 2 PEPTIDE; MELANIN CONCENTRATING HORMONE; METASTIN; MOTILIN; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE S; OMEGA CONOTOXIN MVIIA; OREXIN; PEPTIDE DERIVATIVE; SIDEROPHORE; THETA DEFENSIN; UNCLASSIFIED DRUG; UROTENSIN II;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANXIETY DISORDER; CAPILLARY ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CEREBROSPINAL FLUID; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG TARGETING; ELECTROSPRAY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST RESISTANCE; HUMAN; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SPERMATOZOON MATURATION; STATISTICAL SIGNIFICANCE; WAKEFULNESS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BETA-DEFENSINS; BLOOD PROTEINS; CARRIER PROTEINS; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN; INSECTS; PEPTIDES;

EID: 9244220099     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2004.10.007     Document Type: Review

References (52)

1. A. Krause, S. Neitz, H.J. Mägert, A. Schulz, W.G. Forssmann, P. Schulz-Knappe, and K. Adermann LEAP-1: A novel highly disulfide-bonded human peptide, exhibits antimicrobial activity FEBS Lett 480 2000 147 150
2. C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 2001 7806 7810
3. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, and O. Loreal A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 276 2001 7811 7819 Describes the discovery of the liver hormone hepcidin through a molecular-biological approach that targets genes upregulated during iron excess. It complements earlier work [1,2], which reported the isolation of the hepcidin peptide from hemofiltrate and urine.
4. G. Nicolas, C. Chauvet, L. Viatte, J.L. Danan, X. Bigard, I. Devaux, C. Beaumont, A. Kahn, and S. Vaulont The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation J Clin Invest 110 2002 1037 1044
5. E. Nemeth, E.V. Valore, M. Territo, G. Schiller, A. Lichtenstein, and T. Ganz Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 2003 2461 2463
6. T. Ganz Hepcidin in iron metabolism Curr Opin Hematol 11 2004 251 254
7. G. Nicolas, L. Viatte, D.Q. Lou, M. Bennoun, C. Beaumont, A. Kahn, N.C. Andrews, and S. Vaulont Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis Nat Genet 34 2003 97 101 Shortly after its discovery, the physiological significance of hepcidin in iron metabolism was demonstrated in an animal model of disease.
8. A. Krause, R. Sillard, B. Kleemeier, E. Klüver, E. Maronde, J.R. Conejo-Garcia, W.G. Forssmann, P. Schulz-Knappe, M.C. Nehls, and F. Wattler Isolation and biochemical characterization of LEAP-2, a novel blood peptide expressed in the liver Protein Sci 12 2003 143 152 Description of a new secretory liver peptide that fulfils the prerequisites of a typical hormone. Its physiological significance remains still to be disclosed.
9. D. Tran, P.A. Tran, Y.Q. Tang, J. Yuan, T. Cole, and M.E. Selsted Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides J Biol Chem 277 2002 3079 3084 A paper that demonstrates the discovery of members of a structurally unique family of antimcrobial peptides with particular biochemical and antimicrobial features. An example that nature provides lead structures for molecular design and engineering.
10. C. Munk, G. Wei, O.O. Yang, A.J. Waring, W. Wang, T. Hong, R.I. Lehrer, N.R. Landau, and A.M. Cole The theta-defensin, retrocyclin, inhibits HIV-1 entry AIDS Res Hum Retroviruses 19 2003 875 881
11. B. Yasin, W. Wang, M. Pang, N. Cheshenko, T. Hong, A.J. Waring, B.C. Herold, E.A. Wagar, and R.I. Lehrer Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry J Virol 78 2004 5147 5156
12. S.M. Owen, D. Rudolph, W. Wang, A.M. Cole, M.A. Sherman, A.J. Waring, R.I. Lehrer, and R.B. Lal A theta-defensin composed exclusively of d-amino acids is active against HIV-1 J Pept Res 63 2004 469 476
13. A.M. Cole Minidefensins and other antimicrobial peptides: candidate anti-HIV microbicides Expert Opin Ther Targets 7 2003 329 341
14. A. Wise, S.C. Jupe, and S. Rees The identification of ligands at orphan G-protein coupled receptors Annu Rev Pharmacol Toxicol 44 2004 43 66 This article comprehensively reviews the selection of target orphan receptors and technologies to discover orphan receptor ligands. The reverse pharmacology approach for investigation of the importance of orphan receptors through the discovery of new ligands is illustrated by recent examples.
15. Y.L. Xu, R.K. Reinscheid, S. Huitron-Resendiz, S.D. Clark, Z. Wang, S.H. Lin, F.A. Brucher, J. Zeng, N.K. Ly, and S.J. Henriksen Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects Neuron 43 2004 487 497
16. V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley, C. Blanpain, and M. Detheux Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids J Exp Med 198 2003 977 985 An example of the isolation of an orphan GPCR employing a knowledge-based approach. Expression data of the receptor provided was used to select a source for ligand isolation.
17. Y. Jiang, L. Luo, E.L. Gustafson, D. Yadav, M. Laverty, N. Murgolo, G. Vassileva, M. Zeng, T.M. Laz, and J. Behan Identification and characterization of a novel RF-amide peptide ligand for orphan G-protein-coupled receptor SP9155 J Biol Chem 278 2003 27652 27657
18. S. Fukusumi, H. Yoshida, R. Fujii, M. Maruyama, H. Komatsu, Y. Habata, Y. Shintani, S. Hinuma, and M. Fujino A new peptidic ligand and its receptor regulating adrenal function in rats J Biol Chem 278 2003 46387 46395
19. H.J. Mägert, L. Ständker, P. Kreutzmann, H.D. Zucht, M. Reinecke, C.P. Sommerhoff, H. Fritz, and W.G. Forssmann LEKTI, a novel 15-domain type of human serine proteinase inhibitor J Biol Chem 274 1999 21499 21502
20. T. Lauber, A. Schulz, K. Schweimer, K. Adermann, and U.C. Marx Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI J Mol Biol 328 2003 205 219 This paper convincingly demonstrates the importance of three-dimensional structural information. The obvious structural differences of the described LEKTI domains provide an explanation for the different protease selectivity, which is not possible by primary structure analysis.
21. K. Mitsudo, A. Jayakumar, Y. Henderson, M.J. Frederick, Y. Kang, M. Wang, A.K. El-Naggar, and G.L. Clayman Inhibition of serine proteinases plasmin, trypsin, subtilisin A, cathepsin G, and elastase by LEKTI: a kinetic analysis Biochemistry 42 2003 3874 3881
22. A.J. Walley, S. Chavanas, M.F. Moffatt, R.M. Esnouf, B. Ubhi, R. Lawrence, K. Wong, G.R. Abecasis, E.Y. Jones, and J.I. Harper Gene polymorphism in Netherton and common atopic disease Nat Genet 29 2001 175 178
23. B.C. Schutte, J.P. Mitros, J.A. Bartlett, J.D. Walters, H.P. Jia, M.J. Welsh, T.L. Casavant, and P.B. McCray Jr. Discovery of five conserved β-defensin gene clusters using a computational search strategy Proc Natl Acad Sci USA 99 2002 2129 2133 Impressive use of bioinformatic tools to discover novel mammalian β-defensins based on primary structure motifs of known β-defensins.
24. J.R. Garcia, A. Krause, S. Schulz, F.J. Rodriguez-Jimenez, E. Klüver, K. Adermann, U. Forssmann, A. Frimpong-Boateng, R. Bals, and W.G. Forssmann Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity FASEB J 15 2001 1819 1821
25. F.J. Rodriguez-Jimenez, A. Krause, S. Schulz, W.G. Forssmann, J.R. Conejo-Garcia, R. Schreeb, and D. Motzkus Distribution of new human β-defensin genes clustered on chromosome 20 in functionally different segments of epididymis Genomics 81 2003 175 183
26. D. Yang, O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, J. Shogan, M. Anderson, J.M. Schroder, J.M. Wang, O.M. Howard, and J.J. Oppenheim β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525 528
27. C.X. Zhou, Y.L. Zhang, L. Xiao, M. Zheng, K.M. Leung, M.Y. Chan, P.S. Lo, L.L. Tsang, H.Y. Wong, and L.S. Ho An epididymis-specific β-defensin is important for the initiation of sperm maturation Nat Cell Biol 6 2004 458 464 This paper clearly indicates a role for a bioinformatically discovered mouse β-defensin beyond innate immunity. A function for sperm maturation was suggested earlier based on the epididymal expression of new β-defensins, which are truly multifunctional endogenous peptides.
28. H. Terlau, and B.M. Olivera Conus venoms: a rich source of novel ion channel-targeted peptides Physiol Rev 84 2004 41 68 A comprehensive overview about a large and extremely diverse peptide family, including details of structural features and activity on ion channels. Although a large number of Conus peptides are already known, most conotoxins and related peptides remain to be discovered.
29. R.M. Jones, and G. Bulaj Conotoxins-new vistas for peptide therapeutics Curr Pharm Des 6 2000 1249 1285
30. R.W. Teichert, J. Rivier, J. Dykert, L. Cervini, J. Gulyas, G. Bulaj, M. Ellison, and B.M. Olivera αA-Conotoxin OIVA defines a new αA-conotoxin subfamily of nicotinic acetylcholine receptor inhibitors Toxicon 44 2004 207 214 An example of the discovery, structural and functional characterization of a peptide of a new conotoxin subfamily.
31. S.A. Doggrell Intrathecal ziconotide for refractory pain Expert Opin Investig Drugs 13 2004 875 877
32. A. Aneiros, and A. Garateix Bioactive peptides from marine sources: pharmacological properties and isolation procedures J Chromatogr B Analyt Technol Biomed Life Sci 803 2004 41 53 A systematic overview of peptides isolated from various marine organisms. Recent discoveries of bioactive peptides from different species are highlighted with respect to structure, function and isolation procedures.
33. S. Diochot, A. Baron, L.D. Rash, E. Deval, P. Escoubas, S. Scarzello, M. Salinas, and M. Lazdunski A new sea anemone peptide, APETx2, inhibits ASIC3, a major acid-sensitive channel in sensory neurons EMBO J 23 2004 1516 1525
34. X. Thomas, D. Destoumieux-Garzon, J. Peduzzi, C. Afonso, A. Blond, N. Birlirakis, C. Goulard, L. Dubost, R. Thai, J.C. Tabet, and S. Rebuffat Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity J Biol Chem 279 2004 28233 28242 Description of a novel post-translational modification of an antibacterial peptide. Modern NMR spectroscopic and mass spectrometric techniques were used to localize and specify the sidechain modification enhancing the antibacterial activity.
35. P. Chilley Polypeptide hormones: signaling molecules in plants Vitam Horm 66 2003 317 344 Overview of the current knowledge of peptides as signal transducers in plants, a field of peptide research that appears to be underrepresented.
36. B.P. Thomma, B.P. Cammue, and K. Thevissen Plant defensins Planta 216 2002 193 202
37. C.A. Ryan, and G. Pearce Systemins: a functionally defined family of peptide signals that regulate defensive genes in Solanaceae species Proc Natl Acad Sci USA 100 Suppl 2 2003 14577 14580
38. D.J. Craik, S. Simonsen, and N.L. Daly The cyclotides: novel macrocyclic peptides as scaffolds in drug design Curr Opin Drug Discov Devel 5 2002 251 260 Peptides of the cyclotide family contain a rigid framework maintained by multiple disulfide bonds. As a consequence, cyclotides display considerable thermal stability and resistance against proteolytic cleavage and are considered to be lead structures for targeted peptide design.
39. C. Jennings, J. West, C. Waine, D. Craik, and M. Anderson Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis Proc Natl Acad Sci USA 98 2001 10614 10619
40. P. Schulz-Knappe, M. Schrader, L. Ständker, R. Richter, R. Hess, M. Jürgens, and W.G. Forssmann Peptide bank generated by large-scale preparation of circulating human peptides J Chromatogr A 776 1997 125 132
41. S. Wittke, T. Kaiser, and H. Mischak Differential polypeptide display: the search for the elusive target J Chromatogr B Analyt Technol Biomed Life Sci 803 2004 17 26
42. K. Rose, L. Bougueleret, T. Baussant, G. Bohm, P. Botti, J. Colinge, I. Cusin, H. Gaertner, A. Gleizes, and M. Heller Industrial-scale proteomics: from liters of plasma to chemically synthesized proteins Proteomics 4 2004 2125 2150
43. K. Wagner, T. Miliotis, G. Marko-Varga, R. Bischoff, and K.K. Unger An automated on-line multidimensional HPLC system for protein and peptide mapping with integrated sample preparation Anal Chem 74 2002 809 820
44. E. Machtejevas, H. John, K. Wagner, L. Ständker, G. Marko-Varga, W.G. Forssmann, R. Bischoff, and K.K. Unger Automated multi-dimensional liquid chromatography: sample preparation and identification of peptides from human blood filtrate J Chromatogr B Analyt Technol Biomed Life Sci 803 2004 121 130
45. M. Soloviev, R. Barry, E. Scrivener, and J. Terrett Combinatorial peptidomics: a generic approach for protein expression profiling J Nanobiotechnology 1 2003 4 18 This article presents a new approach to identify peptides from complex mixtures making a chromatographic separation unnecessary. Serial covalent immobilization using selective crosslinking of peptide sidechain functional groups to polymeric beads is used to remove certain peptides from the mixture. This approach is suitable for quantification.
46. G. Baggermann, A. Cerstiaens, A. De Loof, and L. Schoofs Peptidomics of the larval Drosophila melanogaster central nervous system J Biol Chem 277 2002 40368 40374 This paper convincingly demonstrates how efficient modern MS can be applied in terms of sensitivity and sequence elucidation. A total of 28 neuropeptides were identified from only 50 larval Drosophila, whereas classical approaches required several 100 000 larvae.
47. M. Ramström, and J. Bergquist Miniaturized proteomics and peptidomics using capillary liquid separation and high resolution mass spectrometry FEBS Lett 567 2004 92 95
48. M. Schrader, and P. Schulz-Knappe Peptidomics technologies for human body fluids Trends Biotechnol 19 Suppl 10 2001 S55 S60
49. T. Kaiser, H. Kamal, A. Rank, H.J. Kolb, E. Holler, A. Ganser, B. Hertenstein, H. Mischak, and E.M. Weissinger Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation Blood 104 2004 340 349 An example of a sophisticated analytical procedure and its application in diagnostics. CE-MS instrumentation combined with bioinformatics has added a new tool to a specific clinical field. A closely related application of this technique is described in [50].
50. Mischak H, Kaiser T, Walden M, Hillmann M, Wittke S, Herrmann A, Knueppel S, Haller H, Fliser D: Proteomic analysis for assessment of diabetic renal damage in humans. Clin Sci (Lond) 2004, doi:10.1042/CS20040103.
51. P. Lewczuk, H. Esselmann, T.W. Groemer, M. Bibl, J.M. Maler, P. Steinacker, M. Otto, J. Kornhuber, and J. Wiltfang Amyloid β peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease Biol Psychiatry 55 2004 524 530
52. K. Sasaki, K. Sato, Y. Akiyama, K. Yanagihara, M. Oka, and K. Yamaguchi Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines Cancer Res 62 2002 4894 4898 Example of the use of SELDI technology to detect potential cancer-related biomarkers. Combination of a less complex test mixture of cultured cell supernatants with selective on-target sample preparation represents a promising application for SELDI-MS broadening its diagnostic value.